Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Cardiovascular Business announces its Forty Under 40 Class of 2026
The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40.
FDA-approved surgical aortic valve implanted for first time in US
The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.
Acute kidney injury after TAVR: Key risk factors every cardiologist should know
Multiple studies have linked acute kidney injury after TAVR to a heightened risk of short- and long-term mortality.
New obesity statistics highlight importance of preventive cardiology
Cardiovascular health is much worse in some parts of the United States than others. Cardiologists in those high-risk areas can make a world of difference by embracing preventive cardiology and working to treat patients before it is too late.
New dyslipidemia guideline puts add-on testing, early screening in the spotlight
The updated recommendations represent a collaboration between the American College of Cardiology, American Heart Association and several other U.S. healthcare organizations.

Benzodiazepine use before heart surgery: Should it be embraced or restricted?

Benzodiazepines are administered before a majority of cardiac surgeries to lower the risk of intraoperative awareness. At the same time, however, recent studies have suggested they increase the risk of postoperative delirium.

AI brings cardiology, neurology teams together to boost care for stroke patients

A new post-stroke care pathway from Viz.ai and Medtronic is associated with significant benefits, including higher patient and clinician satisfaction.

The U.S. Food and Drug Administration (FDA) has shared a new warning about ongoing safety issues with atherectomy devices sold and distributed by Bard Peripheral Vascular, an Arizona-based subsidiary of Becton, Dickinson and Company (BD). The warning includes multiple models of Bard Peripheral Vascular’s Rotarex Atherectomy System, which is designed to target high-risk plaques and blood clots in the peripheral arteries by rotating at a high speed.

FDA warns that atherectomy devices are breaking during use—30 serious injuries, 4 deaths reported

More than 100 incidents have been reported so far. The FDA is still evaluating this issue, but the agency wanted to raise awareness as quickly as possible.

artificial intelligence AI in healthcare

Healthcare AI Digest

People are still asking if AI will replace doctors or other healthcare workers.

Healthcare systems are proceeding apace with GenAI—and learning as they go

Last summer more than 40% of 121 hospital executives surveyed said their organization had already realized a decent ROI in generative AI. However, a C-suite slice of nearly the same size said it was too soon to know for sure.

FDA warns that smartphone-compatible diabetes devices may not work properly

Smartphones have made it easier than ever for patients to monitor their own health, but the technology is far from infallible.

Heart failure patients see benefits from home-based rehab

Many heart failure patients still skip cardiac rehab altogether. Offering a home-based option could potentially help reverse that trend.

Healthcare AI Digest

Don’t judge DeepSeek on the innovativeness of its programming. Judge it on the degree to which it shakes up the economics of the AI market.

Care Delivery

Cardiovascular Business announces its Forty Under 40 Class of 2026

FDA-approved surgical aortic valve implanted for first time in US

Acute kidney injury after TAVR: Key risk factors every cardiologist should know

New obesity statistics highlight importance of preventive cardiology

New dyslipidemia guideline puts add-on testing, early screening in the spotlight